Gujarat Themis Biosyn to acquire Sanofi’s global anti-TB and anti-infective brands portfolio; asset-light deal with regulatory approvals needed, expanding GTBL’s global footprint and forward integration.
AI Assistant
Gujarat Themis Biosyn Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.